[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Oman Ministry of Health\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":191},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,40,72,104,130,160],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100644855","ice-cold-water-flushing-of-the-ampulla-after-endoscopic-sphincterotomy-to-reduce-post-ercp-pancreatitis-100644855",false,"NCT07677397","Ice Cold Water Flushing of the Ampulla After Endoscopic Sphincterotomy to Reduce Post-ERCP Pancreatitis","A Multicenter Randomized Controlled Trial of Ice Cold Water Flushing of the Ampulla After Endoscopic Sphincterotomy to Reduce Post-ERCP Pancreatitis","ERCP","Inclusion Criteria:\n\n* All adults (agesld 18 years old) scheduled for an endoscopic sphincterotomy at the participating hospitals.\n\nExclusion Criteria:\n\n* Patients with missing data, acute or chronic pancreatitis, pancreatic cancer, or those unable to provide informed consent.","ALL","18 Years",{"count":20,"type":21},210,"ESTIMATED","INTERVENTIONAL",[24],"NA","Endoscopic retrograde cholangiopancreatography (ERCP) is an essential diagnostic and therapeutic tool used to manage diseases of the pancreatic and biliary systems. During the procedure, an upper endoscope is used to reach the major duodenal papilla, and a contrast material is injected into the ducts for radiologic imaging. In an endoscopic sphincterotomy, a specialized knife cuts the biliary sphincter to treat papilla conditions or facilitate therapeutic interventions.\n\nThe most common complication following an ERCP is pancreatitis, carrying an incidence rate of 3.5% to 9.7%. Standard preventive strategies currently include careful patient selection, rectal administration of NSAIDs (like indomethacin or diclofenac), aggressive intravenous hydration, and pancreatic stent placement.\n\nThe Innovation: Flushing the ampulla with ice-cold water after a sphincterotomy is a safe,easy, and cost-effective evolving intervention. While initial data demonstrates its safety,there is a clear deficiency in multicenter randomized trials assessing its overall clinical effectiveness, and no such studies have been conducted in the Gulf region. The primary goal of this study is to evaluate the effectiveness of ice-cold water flushing ofthe ampulla after endoscopic sphincterotomy in reducing the incidence of post-ERCP pancreatitis.",[27],"Post ERCP Pancreatitis","NOT_YET_RECRUITING","2026-06-27",{"date":31,"type":32},"2026-06-30","ACTUAL",{"date":34,"type":21},"2026-06-28",{"date":36,"type":21},"2027-06-30",{"name":38,"class":39},"Oman Ministry of Health","OTHER_GOV",{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":22,"phases":50,"briefSummary":51,"conditions":52,"keywords":55,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":4},"100641748","the-effect-of-motivational-interviewing-on-treatment-adherence-and-self-efficacy-among-omani-adults-with-thalassemia-100641748","NCT07660224","The Effect of Motivational Interviewing on Treatment Adherence and Self-Efficacy Among Omani Adults With Thalassemia","The Effect of Motivational Interviewing on Treatment Adherence and Self-Efficacy Among Omani Adults With Beta-Thalassemia Major","MITAS","Inclusion Criteria:\n\n* Adults aged 18 years and older.\n* Diagnosed with transfusion-dependent beta-thalassemia major.\n* Receiving iron chelation therapy for at least 6 months.\n* Receiving regular follow-up at the participating study sites.\n* Able to communicate in Arabic or English.\n* Willing and able to provide informed consent.\n* Able to attend the motivational interviewing sessions and complete study questionnaires.\n\nExclusion Criteria:\n\n* Current hospitalization for an acute medical condition at the time of recruitment.\n* Severe cognitive impairment or psychiatric illness that may affect participation.\n* Participation in another structured psychosocial or behavioral intervention program.\n* Unable or unwilling to provide informed consent.",{"count":49,"type":21},45,[24],"Beta-thalassemia major is a chronic hereditary blood disorder that requires lifelong treatment, including regular blood transfusions and iron chelation therapy. Poor adherence to treatment remains a significant challenge and may lead to iron overload and related complications. Self-efficacy is an important factor influencing patients' ability to adhere to treatment recommendations.\n\nThis study aims to evaluate the effect of nurse-delivered Motivational Interviewing (MI) on treatment adherence and self-efficacy among Omani adults with beta-thalassemia major. A pre-experimental one-group repeated-measures design will be used. Approximately 45 participants will be recruited from the Oman National Center for Hematology and Bone Marrow Transplantation and Royal Hospital in Muscat, Oman.\n\nParticipants will receive three individualized MI sessions over a period of six to eight weeks. Treatment adherence and self-efficacy will be assessed at baseline, immediately after completion of the intervention, and at three-month follow-up. Secondary outcomes include serum ferritin level and frequency of thalassemia-related hospital admissions. The findings will provide evidence regarding the usefulness of motivational interviewing in improving adherence-related outcomes among adults with beta-thalassemia major.",[53,54],"Beta-Thalassemia Major","Transfusion-Dependent Thalassemia",[56,53,57,58,59,60,61,62,63],"Motivational Interviewing","Treatment Adherence","Self-Efficacy","Iron Chelation Therapy","Adult Patients","Nursing Intervention","Thalassemia","Oman","2026-06-16",{"date":66,"type":32},"2026-06-22",{"date":68,"type":21},"2026-11-01",{"date":70,"type":21},"2027-11-30",{"name":38,"class":39},{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":17,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":4,"studyType":22,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},"100624701","phase-3-comparative-efficacy-of-4-mg-vs-8-mg-submucosal-dexamethasone-in-postoperative-pain-management-after-dental-implant-surgery-a-randomized-double-blind-controlled-clinical-trial-100624701","NCT07413055","Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial","Comparative Efficacy of 4 mg vs. 8 mg Submucosal Dexamethasone in Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial","Inclusion Criteria:\n\n* Males \\& females\n* Age range (21-80)\n* ASA I \\& II according to (American Society of Anesthesiologists) classification\n* Single tooth implant\n* Type 3 \\& type 4 implant placement timing (Chen and Buser, 2009)\n\nExclusion Criteria:\n\n* Any known allergy to any medications which will be used in the study\n* Smokers\u002F Alcoholics\n* Pregnant and lactating women\n* Bone augmentation\u002F sinus lifting required during the surgery\n* The need of antibiotic prophylaxis","21 Years","80 Years",{"count":82,"type":21},138,[84],"PHASE3","This study aims to compare the effectiveness of 4mg and 8mg dexamethasone administered submucosally in reducing postoperative pain after dental implant surgery. Participants will be randomly assigned to receive either 4mg dexamethasone, 8mg dexamethasone, or a placebo (normal saline) at the surgical site.\n\nLater, postoperative pain will be assessed using a Visual Analog Scale at 6 hours after the surgery and daily for the next 6 days. Also the number of pain-relief tablets consumed after the surgery will be recorded.\n\nPreoperative anxiety will be assessed using Generalized Anxiety Disorder-7 (GAD-7) questionnaire to assess its association with postoperative pain scores.\n\nThe results of this study will help determine the optimal dose of dexamethasone that is effective for postoperative pain control following dental implant surgery.",[87],"Postoperative Pain",[89,90,91,92,93,94],"Dexamethasone","Dental implants","Postoperative pain","Submucosal injection","Analgesic consumption","Anxiety","RECRUITING","2026-03-25",{"date":98,"type":32},"2026-03-30",{"date":96,"type":21},{"date":101,"type":21},"2026-12-01",{"name":38,"class":39},1,{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":17,"minAge":111,"maxAge":4,"enrollmentInfo":112,"targetDuration":4,"studyType":22,"phases":114,"briefSummary":115,"conditions":116,"keywords":118,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":103},"100630697","impact-of-sglt2-inhibitors-on-chronic-peritoneal-dialysis-patients-100630697","NCT07491042","Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.","Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients: A Six-month Prospective .Study","Inclusion Criteria:\n\n* o age equal to or more than13 years.\n\n  * All genders.\n  * All patients undergoing chronic Peritoneal Dialysis.\n  * Urine output equal or more than 150 ml\u002F24 hours.\n\nExclusion Criteria:\n\n* o Age less than 13 years\n\n  * Patients with type I diabetes mellitus.\n  * Patients with recurrent urinary tract infection (UTI) or peripheral vascular diseases (P.V.D).\n  * Patients with urine output less than 150 ml\u002F24hours.\n  * Patients with recurrent hypoglycemic episodes\n  * Patients with acute or chronic liver disease,\n  * Patients who refuse to participate in the study.\n  * peritoneal Dialysis catheter (PDC) related peritonitis in last 3 months","13 Years",{"count":113,"type":21},38,[24],"This project aims to examine the effects of six-month treatment with selective SGLT2 inhibitor dapagliflozin in patients with end-stage kidney disease on chronic peritoneal dialysis.\n\nMethods: A prospective, open label, single-arm interventional clinical trial, will conduct at Nizwa Hospital from March 1st, 2026, to August 31th , 2026, and includes thirty (30) end-stage kidney disease diabetic and non-diabetic patients on chronic peritoneal dialysis, will receive selective SGLT2i Dapagliflozin 10 mg once daily (OD). Clinical and laboratory parameters will be assessed at baseline, then three and six months after drug initiation.\n\nThe primary outcomes are:1- change in ultrafiltration volume, 2- change in Kt\u002FV (dialysis adequacy), 3. Change in the mean 24-hour urine volume.",[117],"End Stage Chronic Renal Failure",[119,120,121],"SGLT-2 inhibitor","Peritoneal Dialysis","urine volume","2026-03-19",{"date":124,"type":32},"2026-03-24",{"date":126,"type":21},"2026-04-01",{"date":128,"type":21},"2027-01-31",{"name":38,"class":39},{"id":131,"slug":132,"hasResults":11,"nctId":133,"briefTitle":134,"officialTitle":135,"acronym":4,"eligibilityCriteria":136,"healthyVolunteers":11,"sex":17,"minAge":137,"maxAge":111,"enrollmentInfo":138,"targetDuration":4,"studyType":22,"phases":140,"briefSummary":141,"conditions":142,"keywords":144,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":152,"lastUpdatePostDateStruct":153,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":103},"100624406","the-use-of-an-audio-visual-method-in-counseling-for-pediatric-lumbar-puncture-procedure-100624406","NCT07409220","The Use of an Audio-visual Method in Counseling for Pediatric Lumbar Puncture Procedure","The Use of an Audio-visual Method in Counseling for Pediatric Lumbar Puncture Procedure. A Randomized Controlled Trial.","Inclusion Criteria:\n\n* All Parents\u002Flegal guardians of 0-13 years old children who were identified to get an emergent lumbar puncture procedure, as decided by the attending physician during the Emergency Department shift.\n* Participants who speak Arabic or English\n\nExclusion Criteria:\n\n\\- Participants who are not Arabic nor English speakers.","12 Hours",{"count":139,"type":21},154,[24],"The goal of this clinical trial is to compare the use of usual verbal counseling supported by a video illustration comparing to the use of usual verbal counseling alone prior to obtaining spinal fluid ( Lumbar puncture - LP ) procedure, from children suspected to have brain infection in the Emergency department settings.\n\nThis trial is trying to answer if use of video illustration is associated with higher acceptance rate for the procedure by the parents of children who are suspected to have brain infection (meningitis) in the pediatric emergency room settings at a tertiary hospital.\n\nWho is suitable to participate? Parents\u002Flegal guardians of all children aged between 1day to 12 years, who are suspected to have brain infection (meningitis) attending the Pediatric emergency room at the Royal Hospital.\n\nParticipants will:\n\nBe counseled using verbal snd video method = Intervention group OR verbal method only = Control group The Researchers will collect the acceptance rate in performing LP in both groups.",[143],"Meningitis in Children",[145,146,147,148,149,150,151],"lumbar puncture","counseling","audiovisual aids","verbal","video","emergency","pediatrics","2026-02-11",{"date":154,"type":32},"2026-02-13",{"date":156,"type":32},"2025-01-31",{"date":158,"type":21},"2026-07-30",{"name":38,"class":39},{"id":161,"slug":162,"hasResults":11,"nctId":163,"briefTitle":164,"officialTitle":165,"acronym":4,"eligibilityCriteria":166,"healthyVolunteers":167,"sex":17,"minAge":79,"maxAge":4,"enrollmentInfo":168,"targetDuration":4,"studyType":22,"phases":170,"briefSummary":171,"conditions":172,"keywords":177,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":103},"100600686","intervention-study-on-compassion-fatigue-and-satisfaction-in-omani-nurses-100600686","NCT07100717","Intervention Study on Compassion Fatigue and Satisfaction in Omani Nurses","Compassion Fatigue and Compassion Satisfaction Among Nurses in Oman: Intervention Study","Inclusion Criteria:\n\n* Registered nurses (males \\& females; Omani \\& Non-Omani)\n* With direct patient care\n* A minimum of six months experience in same hospital's unit\u002Fword\n* Currently not receiving psychiatric or mental therapy\n\nExclusion Criteria:\n\n* Registered nurses with no direct patient care\n* Less than six months of work experience in a hospital unit\u002Fword\n* Currently under psychiatric or mental therapy",true,{"count":169,"type":21},50,[24],"The purpose of this study is to assess the level of compassion fatigue and compassion satisfaction among nurses working at Ministry of Health hospitals. It will also examine the significant demographics, work-related contributing factors, and the impact of a mindfulness self-care program on nurses' compassion fatigue and compassion satisfaction level.",[173,174,175,176],"Registered Nurses","Compassion Fatigue","Occupational Stress","Mental Health",[178,63,174,179,180,181,182,176],"Nurses","Compassion Satisfaction","Burnout","Intervention","Healthcare Workers","2025-07-27",{"date":185,"type":32},"2025-08-03",{"date":187,"type":21},"2025-09-21",{"date":189,"type":21},"2027-12-31",{"name":38,"class":39},""]